Identical Brains (IDENTICAL)

Turnaround

Score breakdown: P/E: 3/3 · ROCE: 1/2 · Growth: 0/2 · Dividend: 0/1

Key Financials

Current Price₹21.7
Market Cap₹26.65 Cr
P/E Ratio9.13
ROCE23.43%
ROE—%
Dividend Yield0%
Profit Growth-43.15%
Debt/Equity
Sales Growth-16.51%
Promoter Holding63.74%
52-Week Range₹14.1 — ₹23.7
SectorEntertainment

Strengths

Concerns

AI Analysis

As I sit with the numbers for Identical Brains, my first thought is caution. Charlie and I always say that the margin of safety comes from understanding the business, but here I am given insufficient data. No book value, no ROE, no debt-equity. What I can see is a tiny media and entertainment company with a market cap of ₹27 crore and a P/E of 9.13. That looks cheap, but cheap can become cheaper when the business is shrinking. Sales are down 16.51% and profits have fallen a steep 43.15%. The Piotroski F-score of 3 out of 9 reinforces my worry — this is not a financially healthy business. The latest quarter shows sales of ₹10 crore and net profit of ₹1 crore, implying a 10% margin, but with declining revenue, that margin may not hold. The ROCE of 23.43% is a bright spot, showing the capital employed is earning well, but if the business keeps contracting, that return will erode. There is zero dividend, so the only way I make money is if the market reprices the stock after a genuine recovery. Promoter holding of 63.74% is good — their interests are aligned with mine — but alignment does not create a moat. This is a potential turnaround, but a turnaround requires evidence of stabilization: sales flattening, profit growth turning positive, and a stronger Piotroski score. Without those, I would rather stay with businesses I can value even at a premium. A low P/E on a declining earnings base is often a value trap, and this one has too many red flags for me to invest today.

Data from BSE/NSE filings. AI analysis is for educational purposes only — not investment advice. Scoring methodology · Disclaimer